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Continuous quality improvement projects and appropriate documentation are an 
essential component to continue to receive Ryan White grant funding.  Compliance with 
mandated aspects of quality improvement is an extremely important concept-specifically 
for a clinic setting that cares for the largest HIV positive population in the state of 
Mississippi.  The Health Resources and Services Administration (HRSA) provides 
directives mandating that quality improvement projects should be applicable to areas of 
need and provide for outcomes that ensure quality care for HIV positive individuals 
(2016). 
Initially, this clinic’s rate of compliance with the HRSA Cervical Cancer 
Screening Performance Measure was subpar to the last reported national average.  Due to 
the increased incidence of cervical dysplasia within the HIV positive female population, 
cervical cancer screening was chosen for improvement focus. The purpose of this Doctor 
of Nursing Practice (DNP) project was to increase the number of HIV positive women 
referred for cervical cancer screening within the clinic setting.  The overall aim of the 
project was to increase cervical cancer screening within this vulnerable population.  
Literature has indicated that provider-initiated referrals provide for increased 
adherence.  A visible, provider-initiated algorithm was introduced for a period of three 
months.  At the end of the project period, pre-and post-intervention referral rates were 
compared to determine project success and significance.  Comparison of collected data 
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CHAPTER I - INTRODUCTION 
HIV affects low-income minorities, specifically in the South, at an alarmingly 
disproportionate rate (Williams, Moneyham, Kempf, Chamot, & Scarinci, 2015).  African 
American women have a disproportionately higher prevalence of both HIV infections and 
cervical cancer (Williams et al., 2015).  Barriers to preventative care such as cervical 
cancer screening cited within minority populations are (a) lack of knowledge of 
resources, (b) denial, (c) fear, (d) competing obligations, and (e) embarrassment (Nonzee 
et al., 2015).  Facilitators to care have been identified as (a) identification of an 
abnormality, (b) provider-initiated actions, (c) motivation from family and friends, and 
(d) patient empowerment through education (Nonzee et al., 2015).  
The Ryan White Comprehensive AIDS Resources Emergency Act of 1990, 
mandates grant recipients to establish and maintain a clinical quality management 
programs ensuring patients provided services with grant funds have access to care that is 
consistent with the most recent Health and Human Service (HHS) Guidelines for 
treatment of Human Immuno-Deficiency (HIV) and prevention of opportunistic 
infections.  Continuous quality improvement efforts are focused on areas that reflect the 
needs of people living with HIV (Health Resources and Service Administration [HRSA], 
2016).  Recommendations for clinical quality management programs include utilization 
of organized, structured processes to implement strategies to align care with current 
guidelines (HRSA, 2016).  
Since the introduction of Highly Active Anti-Retroviral Therapy (HAART), the 
life expectancy of HIV positive individuals adhering to HAART therapy, closely 
resembles that of the HIV negative patient, effectively shifting HIV from a terminal 
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diagnosis to a chronic manageable condition (Cross et al., 2014; Simenson et al., 2014).  
Due to the increase in lifespan, more emphasis is now placed on preventive health 
measures (Cross et al., 2014; Koethe, Moore, & Wagner, 2008).  One such preventative 
measure is cervical cancer screening.  
Cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC) are 
increased within the HIV positive population (Aberg et al., 2014; Brogly et al., 2007; 
Denslow, Rositch, Firnhaber, Ting, & Smith, 2014).  Women who are HIV positive have 
a rate of ICC that is four to five times higher than HIV negative women (Aberg et al., 
2014; Brogly et al. 2007; Denslow et al., 2014).  In 1993, due to the link between HIV 
and invasive cervical cancer, the Center for Disease Control and Prevention (CDC) 
categorized ICC as an Acquired Immuno-Deficiency Syndrome (AIDS) defining illness 
(National Institute of Health, 2011).  
Despite this increased risk, cervical cancer screening remains suboptimal within 
the HIV positive female population (Baranoski, Horsburgh, Cupples, Ashcengrau, & 
Stier, 2011; Frazier et al., 2016), only 50-60% of HIV positive females report being 
screened at least once in the three-year period (Baranoski et al., 2011; Leece et al., 2010).  
Comparatively, the 2010 National Health Interview Survey reported the general female 
population cervical cancer screening rate to be 83% (CDC, 2012).  HIV positive women 
also present for cervical cancer screening, diagnosis, and management at a later stage of 
the disease resulting in a negative impact on prognosis (Logan, Khambaty, D’Souza, & 




Background and Significance 
Incidence of high-grade cervical intraepithelial lesions (CIN 2+) have been 
documented as having a median three-fold increase in HIV positive females and 
progression from a low-grade to a high-grade lesion is also significantly faster (Denslow 
et al., 2014).  Due to these factors, commencement of cervical cancer screening is 
recommended to start within one year of initiating sexual activity but no later than 21 
years of age even if the transmission was perinatal (“Panel on Opportunistic Infections,” 
2013).  Follow up for atypical squamous cells of undetermined significance (ASC-US) 
and low-grade squamous intraepithelial lesions (LSIL) found on cervical cytology is also 
handled differently, requiring referral and follow-up with colposcopy (“Panel on 
Opportunistic Infections,” 2013). 
Globally, researchers have reported nearly all cases of cervical cancer and 
cervical dysplasia are attributable to infection with the human papilloma virus (HPV) 
with presence of the virus detected in 99.7% of cervical cancer cases (Frumovitz, 2017).  
Two specific strains of HPV, 16 and 18, are highly oncogenic and together they account 
for 70% of cases worldwide (World Health Organization [WHO], 2016).  Approximately 
80% of sexually active individuals are exposed to HPV within the first two years of 
initiating sexual activity.  
Compared to HIV negative women who often clear the virus within two to 
twenty-fours months after infection, HIV positive women often have HPV infections that 
persist (WHO, 2016).  Researchers have reported that between 25-44.9% of HIV infected 
women with normal cervical cytology were infected with oncogenic strains of HPV 
(Cubie, Seagar, Beattie, Monaghan, & Williams, 2000; Musa et al., 2013).  On average 
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HPV infections take 5-10 years to progress to cervical cancer in the HIV infected female 
population as compared to 15-20 years in HIV negative females (WHO, 2016). 
Review of Evidence 
A review of the evidence was conducted in two parts.  Initial search was focused 
on determining the significance of failing to perform recommended cervical cancer 
screening.  After determination that cervical cancer screening was a significant aspect of 
care for the HIV positive female a secondary search was focused on specific barriers to 
screening and recommendations that would facilitate adherence to screening and improve 
quality of care for HIV positive women. 
Databases searched included the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) with full text, Medline, and PubMed.  The following key search 
terms were initially utilized for significance and background: HIV, HPV, cervical cancer, 
screening, incidence, progression, and dysplasia.  An initial search limited to full text, 
English only with publication dates between 2012 and 2017 yielded 943 articles.  After 
removal of duplicates 467 articles were available and after narrowing the search to only 
women in the United States 57 articles were left for review.  Abstracts, titles, and 
publication dates were used to determine which articles would receive further review. 
After review of evidence related to the significance and background of the 
problem, CINAHL with full text, Medline, and PubMed were again searched to include 
the following key search terms: HIV, cervical cancer screening, pap smears, preventive 
health care, barriers, and facilitators.  An initial search limited to full text, English only 
with publication dates between 2012 and 2017 yielded 460 articles.  After removal of 
duplicates 283 articles were available and after narrowing the search to only women in 
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the United States 92 articles were left for review.  During this second phase of evidence 
review, abstracts, titles, and publication dates were again used as criteria to determine 
articles that received further review. 
Review of available reference lists revealed another 20 previously published 
articles that were included for consideration.  In total, there were 23 articles that were 
selected for inclusion due to strength and applicability to this quality improvement 
project.  Articles chosen were related to (a) the increased incidence or prevalence of 
cervical dysplasia seen in the HIV positive population, (b) progression of cervical lesions, 
(c) identified facilitators and barriers to cervical cancer screening in HIV positive 
females, and (d) expert guidelines.  A literature matrix is included with information from 
each of the chosen articles (see Appendix A).  
Cervical Dysplasia 
In a systematic global review conducted by Denslow and colleagues (2014), 15 
studies met inclusion criteria to evaluate incidence of cervical dysplasia in HIV positive 
women; N=5882.  The data extrapolated from these studies showed that per 100 life-
years studied, incidence of any cervical lesion was between 4.9-21.1 cases for HIV 
infected females.  Incidence of high-grade cervical lesions was between 0.4-8.8 cases per 
100 life-years.  There was a median three-fold increase of cervical lesions in HIV 
positive women when compared to HIV negative women (Denslow et al., 2014, p. 164).  
In the same systematic global review conducted by Denslow and colleagues 
(2014), 11 studies were reviewed to measure progression of cervical lesions; N=1099.  
Data deduced from these studies indicated progression from a low- to high- grade lesion 
to range between 1.2-26.2 cases per 100 life-years for HIV positive women.  HIV 
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positive women were also found to be twice as likely to have progression of cervical 
lesions when compared to HIV negative women (Denslow et al., 2014, p. 169). 
Brogly and colleagues (2007) found the prevalence of atypical squamous cells of 
undetermined significance (ASC-US) or higher cervical abnormality found on first 
screening within the HIV positive, perinatally infected, female population was 29.7%, 
N=101.  Of the 21 girls who underwent appropriate follow-up, 47.6% of cases either 
persisted or progressed to a more invasive lesion despite colposcopy, cryotherapy, 
excision, or a combination.  Fourteen HIV positive, perinataly infected females did not 
undergo intervention and seven cases persisted or progressed to a more invasive lesions 
(Brogly et al., 2007). 
In a retrospective cohort review of medical records of HIV positive women 
receiving care from January 1, 2002 to December 31, 2006 at an HIV clinic located in the 
Western United States, 69 women met inclusion criteria for chart review.  Of the 69 
women, 77.9% had at least one cervical screening during the study period (Rahangdale, 
Sarnquist, Yavari, Blumenthal, & Israelski, 2010).  The collected cytology yielded 66.9% 
normal findings and 33.3% abnormal findings.  Abnormalities identified were 50.9% 
ASC-US, 36.4% LSIL, 10.9% high-grade intraepithelial lesion (HSIL), and 1.8% atypical 
glandular cells of undetermined significance (Rahangdale et al., 2010).  Only 62% of 
women who had an abnormality identified on cytology had documented follow up within 
12 months (Rahangdale et al., 2010).  
Barriers to Screening 
Factors that have been associated with non-adherence to cervical cancer screening 
include (a) being in a racial minority, (b) lacking insurance coverage, and (c) not 
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receiving cervical cancer screening at the same location as primary HIV care (Frazier et 
al., 2016).  Although lack of insurance coverage has been noted as a barrier to cervical 
cancer screening, having private insurance has also demonstrated decreased adherence 
rates (Simonsen et al., 2014).  A retrospective cohort study of HIV positive women 
receiving care at an HIV clinic associated with the University of Utah reported a 
statistically significant correlation between having private health insurance coverage and 
not having had cervical cancer screening, p=0.025 (Simonsen et al., 2014).  Researchers 
noted that this correlation could be related to the copay that women with private 
insurance are likely required to pay to receive services from an outside clinic (Simonsen 
et al., 2014).  
Fletcher et al. (2014) found that notable barriers to cervical cancer screening in 
HIV positive females are (a) lack of education on the importance of screening, (b) lack of 
education that cervical cancer can be prevented with appropriate screening, and (c) 
difficulties with scheduling and remembering appointments for gynecological services.  
The barriers reported by Fletcher et al. (2014) were derived from interviews conducted as 
part of a qualitative focus group of 33 HIV positive females receiving care at a health 
center located in Houston, Texas.  The women who participated in this study were 
predominantly African American, and had a median age of 51 years (Fletcher et al., 
2014). 
In a retrospective chart review of 200 randomly selected charts of HIV positive 
women receiving care in a health department setting, lack of insurance was found to be a 
statistically significant barrier to cervical cancer screening (Logan et al., 2010).  
Researchers reported that 64.7% of women who did not receive a pap smear were 
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uninsured, p=0.0185 (Logan et al., 2010).  The HIV positive women receiving care in this 
clinic were also found to be predominantly minorities—57.4% African American and 
22.8% Hispanic (Logan et al., 2010).  They were also found to be economically 
disadvantaged with a mean income of $8,180 annually (Logan et al., 2010). 
Andrasik, Rose, Pereira, and Antoni (2008) used Anderson’s Behavioral Model of 
Health Services to identify barriers in 35 HIV positive African American women who 
had not received cervical cancer screening within the past five years.  These researchers 
noted primary barriers to be (a) low self-esteem, (b) fear, (c) financial distress, and (d) 
lack of transportation.  This study also highlighted the impact that psychological barriers 
have on HIV positive women when attempting to obtain cervical cancer screening 
services (Andrasik et al., 2008).  
Another retrospective chart review of 148 HIV positive females receiving care at 
a clinic located in New Haven, Connecticut found that cervical cancer screening 
adherence rates were lowest among patients being cared for by infectious disease 
specialists (Koethe, Moore, & Wagner, 2008).  The HIV positive females under the care 
of infectious disease specialists were found to have a 47% compliance rate of cervical 
cancer screening (Koethe et al., 2008).  Comparatively, HIV positive women receiving 
HIV primary care from a generalist, not specialized in infectious disease were found to 
have a cervical cancer screening rate of 55% (Koethe et al., 2008). 
Facilitators to Screening 
Nonzee et al. (2015) conducted semi-structured interviews based on the Social-
Ecological Model integrated with the Theory of Reasoned Action to determine factors 
that facilitated cervical and breast cancer screening within low-income, minority women.   
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The participants were elicited from three health care facilities located in Chicago, Illinois.  
Adherence to recommended cervical cancer screening within the minority population 
studied were facilitated by provider-initiated actions such as: (a) education on importance 
of screening, (b) recommendation for appropriate screening intervals, and (c) referrals 
(Nonzee et al., 2015).  
In a retrospective cohort study conducted by Baronski and Stier (2012), factors 
that contributed to appropriate follow-up after abnormal cervical cytology were found to 
be (a) higher education level of the patient, (b) high-grade cervical lesion identified, and 
(c) abnormality found by a nurse practitioner (NP) performing women’s healthcare 
within the same clinic the patient was receiving HIV primary care.  Time to follow up for 
abnormalities found by the HIV NP were significantly faster when compared to both 
infectious disease physicians at the same clinic and providers at the gynecological clinic 
(Baronski & Stier, 2012).  Decreased time to follow-up is important because lapses of 
time greater than 6 months between abnormal findings on the index cytology and follow-
up with colposcopy for histological evaluation have been cited as increasing negative 
health outcomes (Baranoski & Stier, 2012). 
Fletcher et al., (2014) conducted focus groups using the Health Belief Model to 
determine themes associated with adherence to cervical cancer screening in HIV positive 
females.  Facilitators were found to be: (a) awareness of increased risk of cervical cancer 
in HIV positive women, (b) awareness that cervical cancer could be prevented with 
appropriate screening, and (c) a trusting relationship with their HIV primary provider.  
Recommendations from this study included integration of cervical cancer screening into 
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HIV primary care and ensuring education concerning this screening was framed as a 
preventative measure (Fletcher et al., 2014). 
Education about risk of cervical cancer as well as early detection producing more 
positive outcomes provided by the patient’s primary HIV provider have been related to 
increased compliance (Cross et al., 2014).  Barriers to appropriate cervical cancer 
screening for HIV positive women include lack of screening being performed by the 
patient’s primary HIV caregiver as well as lack of coordination of HIV and women’s 
healthcare at one location (Frazier et al., 2016).  Due to the increased compliance of HIV 
positive women who receive cervical cancer screening at their primary HIV provider, 
integration of women’s health services within this setting is a common theme to increase 
cervical cancer screening (Baronski & Stier, 2012; Frazier et al., 2016; Oster, Sullivan & 
Blair, 2009).  
Synthesis of Evidence 
Identification of facilitators and barriers through synthesis of literature was 
important to this project.  The project structure accounted for specific aspects of barriers 
and facilitator within its design.  The visual algorithm addressed these barriers by (a) 
prompting the provider to make the patient aware of the availability to receive the 
cervical cancer screening within the clinic setting, (b) addressing the importance of 
cervical cancer screening by educating the patient on the increased risk, (c) addressing 
patient fear by educating the patient on the ease of cervical cancer prevention and 
treatment with early and appropriate screening, (d) addressing competing obligations by 
offering the ability of a same day appointment or scheduling an appointment at the 
convenience of the patient, and (e) decreasing embarrassment by having a female NP 
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who is experienced in various aspects of women’s health in vulnerable populations 
perform the screening. 
A synthesis of the literature showed an elevated risk of cervical dysplasia in HIV 
positive women that is significantly increased when compared to HIV negative women 
(Brogly, 2007; Denslow et al., 2014; Rahangdale et al., 2010).  Barriers to screening are 
many and have been cited as stemming from sociocultural factors as well as features that 
interfere with the structural and systematic process of referral for cervical cancer 
screening.  Evidence supports integration of women’s health services within the setting of 
HIV primary care (Baronski & Stier, 2012; Frazier et al., 2016; Oster et al., 2009). 
Needs Assessment 
Researchers have reported suboptimal rates of cervical cancer screening within 
the HIV positive population (Williams et al., 2015).  Discrepancies have also been noted 
between self-report and documented evidence of cervical cancer screening.  In a study 
conducted by Frazier and colleagues (2016), 78% of HIV positive females self-reported 
having a pap smear within the year proceeding the interview; however, researchers could 
find documented receipt of cervical cancer screening in only 45% of the respondents. 
Lack of appropriate cervical cancer screening has been evidenced both nationally 
and at this clinic location.  Per data reported from 126 clinics, located in various locations 
throughout the United States that receive Ryan White Part C and D funds the mean for 
the 2011 reporting year, for the cervical cancer screening measure was 60%, N=2793 
(National Quality Center, 2013).  This project location had an initial cervical cancer 
screening compliance rate of 32%, half of the 2011 reported national average. 
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Researchers report that providing women’s health within the same clinical setting 
as HIV primary care greatly increases the likelihood of follow-up for preventative health 
maintenance, such as cervical cancer screening (Baronski & Stier, 2012; Frazier et al., 
2016; Oster et al., 2009).  The staffing matrix of this clinic includes: three full-time nurse 
practitioners, one part-time nurse practitioner, and four part-time physicians who provide 
HIV care to this population.  The full-time providers have a patient load of approximately 
450 patients, and the part-time providers have between 50-150 patients.  This case load 
does not allow for the primary HIV provider to perform cervical cancer screening during 
clinic visits. 
A chart review of every female who was actively receiving services within the 
clinic was performed to evaluate the status of cervical cancer screening.  If the patient 
had a hysterectomy for non-malignant conditions, records were updated accordingly.  
Charts were also reviewed to identify women who may have had cervical cancer 
screening at an outside provider, such as a local health department or a private clinic.   
If the patient received testing at a site affiliated with the clinic location, the 
cytology results would be available within the electronic medical record EPIC; however, 
this data does not directly transfer into the federal information system (CAREWare) that 
is used to report data to HRSA.  To import the patient information, the data was 
extrapolated from EPIC and manually entered in to CAREWare.  The retrieved data was 
then organized into an Excel sheet to be filtered, sorted, and validated. 
Following informal discussions with the clinic providers concerning lack of 
cervical cancer screening, it was clear that this was not a health service the providers 
could integrate in to the clinic schedule.  The constraints noted were (a) lack of time, (b) 
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competing priorities concerning patients’ healthcare needs, and (c) forgetting to inquire 
about health maintenance history.  Value stream mapping was conducted to determine 
specific strategies to facilitate cervical cancer screening within the clinic. 
Historically, ambulatory referrals were placed within EPIC, for gynecological 
services, but only a small percentage of women followed up for these appointments. 
Approximately 80% of the clinic’s female patients do not have health insurance and 
nearly all (95%) fall within 200% of the federal poverty level.  These limited resources 
make procurement of the recommended cervical cancer screening unobtainable from a 
source outside of this clinic’s setting.  Researchers have reported that HIV positive 
females face additional barriers such as shame and stigma when attempting to receive 
women’s health services from a provider other than their primary HIV provider 
(Andrasik et al., 2008; Baranoski, et al., 2011; Bynum et al., 2016; Cross et al., 2014; 
Fletcher et al., 2014; Frazier et al., 2016).   
Since cervical cancer screening guidelines for HIV positive females are set by the 
CDC and monitored by HRSA as a standard of care, cervical cancer screening is 
financially supported by grant funding.  By increasing referrals to an in-house provider 
for cervical cancer screening, the cost can be covered by grant funds for those patients 
that qualify, and if abnormalities are found, case managers are available to help the 
patient apply for a financial assistance program provided for through the academic 
medical center.  This financial assistance allows the patient to receive appropriate follow-




Cervical dysplasia, the precursor to cervical cancer is seen in 20-40 % of all HIV 
infected women and progression to invasive cervical cancer is largely preventable with 
appropriate cervical cancer screening (Cross et al., 2014).  If cytology results within this 
clinic follows the previously documented trajectory, an estimated 111-222 women will 
present with cervical dysplasia.  Ignoring this important health screening could lead to 
higher incidence of invasive cervical cancer.  ICC without lymph node involvement 
results in radical hysterectomy.  Cancer that has metastasized to pelvic or paraaortic 
lymph nodes results in a poor prognosis regardless of systemic chemotherapy treatment 
(Frumovitz, 2016).  Receipt of a cancer diagnosis of any type can decreases quality of life 
and drastically impact healthcare costs.  
Quality improvement initiatives focused on increasing cervical cancer screening 
of the HIV positive female population are integral to improving patient outcomes. 
Compliance with guidelines set forth by HHS concerning appropriate care of the HIV 
positive female patient will ensure continued program funding and sustainability.  
Continued quality improvement measures and program sustainability impact aggregate 
population health.  
Project Purpose 
This project’s goal was to create a systematic process change that would increase 
provider-initiated referrals for HIV clinic-based cervical cancer screening.  Achievement 
of this goal would support the overall aim of increasing the number of HIV positive 
women being appropriately screened for cervical cancer.  The long-term goal to improve 
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population health would be achieved by the impact and sustainability of this quality 
improvement intervention.    
Theoretical Framework 
This project was built around Donabedian’s Structure-Process-Outcomes Quality 
Improvement Model.  Donabedian’s Quality Improvement Model lays out three 
pathways: (a) structure, (b) process, and (c) outcome to evaluate health care (Donabedian, 
1980).  The structure of health care is constituted by both support provided for quality 
care and the environment in which the care is provided (Donabedian, 1982).  Appropriate 
and available supplies, equipment, proficiency of healthcare personnel as well as barriers 
and facilitators to both access and care are all encompassed within structure (Donabedian, 
1982).  Process includes patient and provider interactions as well as the provider’s 
technical proficiency.  The process of providing health care that meets evidenced-based 
guidelines and practice standards is the measurement of quality of care (Hickey & 
Brosnan, 2012).  Donabedian (1980) postulated that process was the primary object of 
study.  The outcome is defined as a measurable change in patient care, effected by both 
structure and process (Donabedian, 1982). 
DNP Essentials 
There are eight essential elements applied to the Doctor of Nursing Practice 
(DNP) degree (American Association of Colleges of Nursing, 2006).  The development 
of this quality improvement project encompasses all eight essentials as follows: 
• Essential I, Scientific Underpinnings for Practice, was achieved by an 
extensive review of available evidence encompassing both quantitative 
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and qualitative studies.  Information was extrapolated and applied to this 
quality improvement project. 
• Essential II, Organization and Systems Leadership for Quality 
Improvement and Systems Thinking, was achieved by examining the 
structure and process within the organization that could be improved upon 
to provide for more positive outcomes within the specified population.  
• Essential III, Clinical Scholarship and Analytical Methods for Evidence-
Based Practice, was met by extensive literature review and analysis of 
available evidence, including expert guidelines, current qualitative and 
quantitative studies, and historical research studies to apply to practice 
improvement.  
• Essential IV, Information Systems/Technology and Patient Care 
Technology, utilized both facility information system-EPIC, as well as 
available federal information system-CAREWare. 
• Essential V, Health Care Policy for Advocacy in Health Care, this 
essential was met because the results of this quality improvement project 
will increase the healthcare outcomes of HIV positive women by 
establishing a visible algorithm for providers to increase utilization of 
available recommended guidelines for cervical cancer screening. 
• Essential VI, Interprofessional Collaboration for Improving Patient and 
Population Health Outcomes, this essential was met by collaboration with 
HIV care providers and other members of the healthcare team to establish 
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a quality improvement project that would improve the health of a unique 
and vulnerable population. 
• Essential VII, Clinical Prevention and Population Health for Improving 
the Nation’s Health, met by constructing a quality improvement plan that 
could be used in other facilities caring for HIV-positive females that may 
be struggling with adherence to appropriate cervical cancer screening. 
• Essential VIII, Advanced Nursing Practice, was met because it provides 
for collaboration between various healthcare providers to achieve common 
goals; collaboration being an essential element in advanced nursing 
practice. 
Summary 
 Chapter one introduced the importance of cervical cancer screening in HIV 
positive women.  This chapter also highlighted the need to increase cervical cancer 
screening within the location chosen for this DNP project.  A thorough review of the 
evidence was performed to identify facilitators and barriers to cervical cancer screening 
that were then used as a framework to build a clinic specific intervention to increase 
referrals to an in-house provider. 
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CHAPTER II – METHODS 
Overview 
Rapid cycles of quality improvement are used within this clinic’s quality program 
infrastructure.  The data extrapolated from these rapid cycles was used to determine the 
best theoretical framework for this quality improvement project.  Inconsistencies were 
found in both the structural and procedural methods of delivering cervical cancer 
screening services.  
Structure within this quality improvement project pertained to the clinic 
environment and providers.  The structure received some previous improvement outside 
of the scope of this project by integration of cervical cancer screening within the HIV 
clinic setting.  Process was evidenced by the provision of provider-initiated referrals for 
cervical cancer screening.  The measured outcome was the number of provider-initiated 
referrals.  
Setting 
The setting for this doctoral project was a large, urban, academic medical center, 
infectious disease clinic that receives Ryan White grant funding.  There are over 1900 
individual HIV positive patients receiving HIV primary care at this location.  Over one-
third of those patients are female, and roughly 80% of the female population still meet 
requirements for cervical cancer screening.  The provider mix includes three full-time 
NPs, one part-time NP, and four part-time physicians specializing in infectious disease.  
Target Population 
The target population was HIV positive females receiving primary care at this 
clinic, N=749.  The demographics of the women were 89.9% African American/Black 
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(n=674), economically disadvantaged, 95.1% (n=712) as evidenced by an annual income 
≤ 200% of the Federal Poverty Level, primarily uninsured, 80.1% (n=600), and between 
the ages of 18 and 60 years old, 90.1% (n=675).  Targeted interest was placed on HIV 
positive women who still had a biological cervix or had undergone hysterectomy for 
malignant conditions, 74.1% (n=555). 
Outcomes of Interest and Evaluation Criteria 
The project had two targeted outcomes of interest that were measured to evaluate 
the impact of the project.  The primary goal of the project was to increase the number of 
provider-initiated referrals for HIV positive females to receive cervical cancer screening 
provided by an in-house resource provider.  To evaluate this goal the use of descriptive 
statistics was used to compare baseline referral rates for cervical cancer screening for the 
three-month period directly preceding the introduction of the intervention to the referral 
rate of the three-month period after introduction of the intervention.  
The overall aim of the project was to increase the number of HIV positive female 
patients, receiving care at this clinic, who also received appropriate cervical cancer 
screening.  This outcome was measured by the percentage of HIV positive female 
patients who received cervical cancer screening.  In a previous article by Cross et al., 
(2014), the introduction of a multidisciplinary quality improvement intervention to 
increase cervical cancer screening increased the rates of HIV positive females 
appropriately screened by 22.3% over a one-year measurement period.  The outcomes for 
this quality improvement initiative were evaluated at three-months.  Comparison to 
achieved outcomes from Cross et al. (2014) any increase ≥ 6% would indicate a success 
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with this quality improvement project’s overall aim of increasing cervical cancer 
screening rates of HIV positive females receiving care at this clinic.  
Outcome 1 
Outcome one was the primary project goal.  The number of HIV positive females, 
receiving primary HIV care in a large, urban, academic medical center who received 
interdepartmental referrals was measured.  Measurement of the referral rate was 
compared at baseline and the following three-months after introduction of a visible 
algorithm.  Project success was determined by an increase in provider initiated cervical 
cancer screening referrals when compared to pre-intervention data.   
Outcome 2 
Outcome two was the project’s overall aim which was to increase the number of 
HIV positive females who received appropriate cervical cancer screening.  Increased 
cervical cancer screening would increase compliance with the HRSA performance 
measure.  The HRSA cervical cancer screening measure would be calculated by the 
number of women receiving cervical cancer screening divided by the number who qualify 
for cervical cancer screening.  
Contextual Elements 
Donabedian (2003) defined the concept of planned reconnaissance as an action 
taken to reveal problems and opportunities for improvement.  This portion of quality 
improvement is completed by routine surveillance by opinion surveys or performance 
monitoring.  Assessment of quality of care could be divided into three approaches: (a) 
structure, (b) process, and (c) outcomes.  Interpretations could not be made by any of 
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these approaches unless there was an encoded relationship amongst each piece 
(Donabedian, 2003).   
Definition of several contextual elements are needed for project clarity and are as 
follows: 
Baseline Referral Rate: Defined as the number of female patients who were provided 
cervical cancer screening by an action that was initiated by their HIV provider.  
Cervical Cancer Screening Performance Measure: The percentage of women, over the 
age of 18, with a biological cervix or a hysterectomy due to malignant conditions, who 
have had cervical cancer screening within the past year, divided by the number of 
women, over the age of 18 who qualify for screening. 
Provider Initiated Referral: Any referral for cervical cancer screening, notated on the 
Ryan White Data Tracking Sheet that was then entered into the CAREWare system by a 
Case Manager for the three-month period of October 24, 2017-January 23, 2018, 
regardless of appointment status.  
Same Day Appointment: Any HIV positive female who required cervical cancer 
screening and requested a same-day appointment-regardless of referral source. 
Design 
After receipt of appropriate approvals, providers and staff were notified by e-mail 
that the previously discussed process for cervical cancer screening referrals had been 
implemented.  This communication clarified the purpose of the algorithm and outlined 
the steps that providers should take to ensure the referral was handled properly.  Specific 




The algorithm (see Appendix B) was laminated and placed in every clinic room 
directly by the computer where the provider sits to document each patient encounter.  The 
algorithm outlined criteria that would qualify a patient for referral for cervical cancer 
screening and included talking points that the provider could use to introduce the 
importance of cervical cancer screening to the patient.  Talking points included: (a) HIV 
positive females are at an increased risk of cervical dysplasia-including cervical cancer, 
(b) cervical cancer is a preventable cancer when appropriate screening is performed, (c) 
cervical cancer screening is available within the clinic setting, and (d) cervical cancer 
screening is a measure of care provided through grant funding for uninsured patients.  
The algorithm included a request that a release of information (ROI) be signed if the 
patient self-reported cervical cancer screening at an outside facility.  Due to study reports 
of discrepancies between self-report and verifiable documentation of cervical cancer 
screening, self-report was not considered evidence of screening (Frazier et al., 2016; 
Howard, Argarwal, & Lytwyn, 2009). 
The algorithm outlined appropriate candidates for cervical cancer screening 
referral.  Key talking points were also included on the algorithm to help the provider 
educate the patient on the importance of cervical cancer screening.  Once the patient 
agreed to be referred for cervical cancer screening, the provider checked the box on the 
Ryan White Data Tracking sheet (see Appendix C) indicating that the patient had been 
referred for cervical cancer screening.  The Ryan White Data Tracking Sheets with the 
cervical cancer screening referral box checked where given to an identified case manager 
at the end of each day.  
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All case managers at this clinic are qualified to enter referrals into CAREWare 
and initiate provider requested referrals.  For simplicity and accuracy during this project 
one identified case manager was chosen to handle aspects of data entry and appointment 
scheduling for cervical cancer screening referrals.  This case manager is a registered 
nurse who also serves on the Continuous Quality Improvement Committee and is well 
versed in use of the CAREWare system and patient care-including referrals.   
The case manager entered the referrals each day into CAREWare and routinely 
called patients to set up appointments for cervical cancer screening.  Same day 
appointments were often available, and she also handled scheduling and facilitation of 
these appointments.  Blinded reports concerning referrals as well as performance measure 
reports measuring the percentage of women appropriately screened was provided to the 
investigator by the case manager at the end of each measurement month and at project 
closure. 
Ethical Considerations 
Ethical considerations for this project were applicable to both the referring 
provider and the patient being referred.  The providers were notified of the project and 
proposed intervention prior to implementation.  All providers had previously agreed to a 
process change concerning referrals for cervical cancer screening, and all providers were 
made aware that the number of women being referred would be counted and reported for 
the purposes of this quality improvement project.  
Assurance was provided that the identity of the referring provider would not be 
made available to this investigator and there would be no reprisal should they choose not 
to comply with the referral guidelines.  If the provider chose not to refer based off the 
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methods outlined in this quality improvement project, there would also be no negative 
effect to the patient.  The patient would still be offered and provided cervical cancer 
screening; however, the referral would not be included within the final project outcomes.   
Ethical consideration was strongly enforced for the patient.  The intervention was 
set up so that the referral would be entered into CAREWare and appointments set up by 
the case manager at the clinic, which is a duty of her position.  This researcher received 
blinded reports, at the end of each month and at project end with information on total 
referrals placed.  The report listed the date of referral for each individual patient and 
identified patient by an encrypted unique record number (eURN).  This eURN is a 
number, generated by the CAREWare program, which includes the patient’s initials, 
birthday, and elements of the social security number in no decipherable order.     
Prior to project approval, the facility Institutional Review Board (IRB) was 
contacted to determine the appropriate ethical actions.  This investigator was informed 
that due to the nature of the project only a Self-Certification Form for Determining 
Whether a Proposed Activity is Research Involving Human Subjects was needed (see 
Appendix D).  Upon completion of the Self-Certification Form the investigator was 
instructed to maintain this document with project records. 
A letter of support (see Appendix E) was obtained from the project director for 
this clinic’s Ryan White Department.  Both the Self-Certification Form and the support 
letter along with IRB application where sent for review by The University of Southern 
Mississippi’s IRB and approval was granted, given Protocol #1710171702 (see Appendix 




Chapter two discussed this project’s setting, target population, and outcomes of 
interest.  The theoretical framework that was chosen to construct this project was also 
discussed.  Contextual elements needed to successfully conduct this project were 




CHAPTER III  - RESULTS 
Comparison of means of pre- and post-intervention referral rates showed a 
significant increase after project implementation.  On average, the provider-initiated 
referrals after introduction of the intervention (M=28, SE=2.082) were significantly 
higher than provider-initiated referrals measured at baseline (M=8, SE=1.732).  The final 
percentage of HIV positive women appropriately screened for cervical cancer also saw a 
23% increase over a three-month period; which was a fourfold increase of the 
improvement noted by Cross et al., (2014).  The increase during the three-month period 
after project implementation was also significantly higher than the 15% increase noted 
during the six-month period prior to introduction of the intervention. 
Table 1  
Mean Comparison of Referral Rates 
Measurement 
 
N M SD Std. Error Mean 
Pre-Intervention 3 8 3 1.732 
Post-Intervention 3 28 3.606 2.082 
 
Table 2  
Data Table: Monthly Provider Initiated Referrals 
Month Provider Initiated Referrals Received 
July 22nd -August 23rd 
2017 
8 









September 24th -October 23rd 
2017 
11 
October 24th -November 23rd 
2017 
32 









Figure 1. Timeline of Project Foundation, Implementation, and Evaluation 
Summary 
Chapter three discussed the results of the project intervention.  Data used to 
determine project success was provided including the mean of pre- and post-intervention 
measurements.  Outcomes from previous quality improvement interventions was 
introduced for comparison. 
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CHAPTER IV – DISCUSSION 
Overview 
At the initiation of the project, the case manager thought it would be beneficial to 
place both release of information (ROI) sheets in each clinic room as well as the quality 
manager’s business card.  This provided a way for an ROI to be obtained by the provider 
without added inconvenience.  The ROIs were turned in with the Ryan White Data 
Tracking sheet so that previous cytology results could be requested.  If the provider 
referred the patient for cervical cancer screening, they could choose to provide the patient 
with a business card that could then be presented at check-out.  For data tracking 
purposes, the provider would still check the referral box for cervical cancer screening. 
The front desk clerk was informed that if they received the quality manager’s business 
card they were to schedule the patient for an appointment for cervical cancer screening. 
This process allowed for some patients to self-schedule for an appointment without the 
case manager having to handle setting up the appointment.  
The algorithm prompted providers to request ROI documents for testing 
performed at outside clinics, and it is possible that this action may have provided an 
unexpected benefit on the increase of women appropriately screened, as it is appropriate 
to count screening performed at an outside clinic given the results have been reviewed 
and verified.  It is also possible that having a specific provider who has clinic time 
devoted to performing cervical cancer screening has a positive impact on the number of 
women screened.  This fact would correlate with the recommendation from available 
literature that women’s health, such as cervical cancer screening, should be incorporated 
with primary HIV care (Baronski & Stier, 2012; Frazier et al., 2016; Oster et al., 2009). 
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Recommendations   
The blinded nature of the data collection greatly reduced this investigator’s ability 
to draw some conclusions.  Infectious disease specialists have been noted as having the 
lowest percentage of performing cervical cancer screening when compared to providers 
of other disciplines (Koethe et al., 2008).  Comparison of referral rates of the clinic 
providers would be a phenomenon of interest to determine if the impact of removing the 
time constraint of screening would increase their willingness to discuss the importance of 
this screening with patients.  Should the data be unblinded later to identify the provider 
who initiated the referral, comparisons could be made between referral rates and provider 
type.   
Recommendations for future investigation would also include retrospective chart 
review to determine how many women referred followed up and review of the cervical 
cytology outcome.  This clinic would be an excellent location to conduct further scholarly 
inquiry on the incidence and progression of cervical dysplasia due to the high number of 
female, HIV positive patients.  For women who were found to have cervical dysplasia 
and had appropriate follow-up, data could also be collected to discern the differences 
between the cervical cytology and the pathology.  One study conducted by Curry, Sage, 
Vragovic, and Stier (2012) reported that 90 HIV positive women with minimally 
abnormal cervical cytology defined as ASC-US with HPV or LSIL received appropriate 
colposcopy and biopsy.  Histological diagnosis included CIN2+ for 29 of these women.  
Further data concerning the variances in cytological screening when compared to 
diagnostic pathology for HIV positive women with cervical dysplasia would have a 
positive impact on the health outcomes for this vulnerable population.  
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Implications for Future Practice 
Implications for future practice that can be extrapolated from this project include 
(a) continuing availability of a provider with dedicated time available to perform cervical 
cancer screening within the same clinic the patient is receiving HIV, (b) visible prompts 
such as the algorithm used in this project could be utilized for other aspects of health care 
that need improvement (i.e. mammography, colonoscopy, immunizations), and (c) 
education and emphasis should be placed on the importance of the patient-provider 
relationship that exists within the HIV care setting.  Visual cues such as the intervention 
used in this project could increase integration of preventative health maintenance in 
similar clinics.  An aging HIV positive population and difficulty accessing health care 
increase the need to integrate preventative health services within HIV specialty care. 
Available literature has provided multiple articles that have statistically examined 
unique variables that may impede cervical cancer screening in HIV positive women. 
There is also well documented evidence of the negative impact on HIV positive women 
who fail to undergo cervical cancer screening.  However, there was only one article 
(Cross et al., 2014) that addressed quality improvement interventions related to 
increasing cervical cancer screening within the HIV positive female cohort.  Due to the 
importance of this preventative screening, it is vital that more quality improvement 
projects be both implemented and disseminated to facilitate structural and procedural 
changes within systems that will impact the long-term health outcomes of HIV positive 




This project, although effective at this location may not be reproducible in a clinic 
setting without a provider with appropriate time to provide cervical cancer screening.  
Due to the aspect of the referrals being blinded to the investigator, it is possible that some 
women were referred inappropriately for cervical cancer screening.  Inappropriate 
referrals would include HIV positive females who had a hysterectomy due to non-
malignant purposes or who had already had appropriate screening within the past year.  
These women, although referred, would not increase the percentage associated with 
cervical cancer screening measure as they either (a) were not included in the denominator 
or (b) were already included in the numerator.  
Dissemination 
Dissemination included discussion of the project’s outcome with both the 
investigator’s preceptor and the clinic’s medical director.  Results were sent via e-mail to 
all clinic staff, along with words of appreciation and gratitude for their conscientious 
efforts to refer their patients for this important screening.  Project overview and outcomes 
were also discussed with HRSA auditors during a recent on-site visit.  This quality 
project will also be submitted for review for the March 23, 2018 meeting of the 
Mississippi Statewide Quality meeting, which is a quality improvement collaborative that 
focuses on improving care for HIV positive patients receiving care through Ryan White 
grant funded clinics.  Plans for future dissemination include submission of a poster 
presentation concerning this quality improvement project during the 2018 National Ryan 
White Conference on HIV Care and Treatment, scheduled for December 11-14, 2018 in 
Washington D.C.  This investigator also plans to submit this work to several HIV/AIDS 
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specific journals.  Project data will be used as the groundwork for further scholarly 
inquiry related to this population.  Possible inquiry includes a retrospective chart review 
of outcome data for concerning incidence of HPV in the presence of normal cervical 
cytology in the HIV positive female patient and incidence and progression of cervical 
dysplasia specific to this clinic’s population. 
Conclusion 
In conclusion, this project was successful, and the intervention was found to 
produce significant increases in provider-initiated referrals.  As previously noted, HIV 
affects women, specifically African American women at a disproportionate rate.  There is 
sufficient evidence that HIV positive women have an increased risk of cervical cancer 
and multiple barriers to receiving cervical cancer screening, but there is minimal 
literature related to the improvement of cervical cancer screening adherence rates.  This 
population would likely benefit from continued scholarly inquiry concerning cervical 
cancer screening improvement measure, including interventions that facilitate adherence.  
Nurses with terminal, clinical degrees such as the Doctor of Nursing Practice are 
positioned to facilitate organizational changes that provide for positive impacts for 
population health.  This quality improvement project has not only changed the referral 
process for HIV positive women but was built on a foundation that effectively 
transformed the clinic’s structure as evidenced by integration of cervical cancer screening 
within the clinic.  Changes instituted in both the structure and process allow for continued 
positive outcomes and sustainability. 
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APPENDIX A – Literature Matrix 
Author/Year Design/Sample/Setting Findings Recommendations 











cytology that is 










female’s lifetime.  
There is no 
recommendation to 
stop screening at 
age 65 as there is in 
HIV negative 
women.  All 
cervical cytology 
that returns 
abnormal should be 
followed-up with 
colposcopy and 
directed biopsy.  
Consideration to 
increase screening 
intervals to every 
three years if the 
female is over age 
30 and cytology is 










using a qualitative 
instrument and open-




HIV positive, females 
ages 18-49 with no 






of Health Services 
as a framework to 







esteem and fear. 
Barriers to 







ensure that patients 













and should proceed 








study of HIV positive 
women, ages 18-60, 
receiving HIV care at 
an urban medical 
center located in 
Boston, MA between 
October 1, 2003 and 
March 31, 2008.  
Multivariate analysis 
with generalized 
estimate equations for 
correlated data. 
N=549 
Risk factors of no 




Subjects (n) only 
53% of women 
engaged in HIV 
care had received 
a pap at any point 
during study 
duration.  
The clinic setting 




and Friday.  The 
primary HIV 
provider could refer 
the patients for pap 





more accurate to 
verify receipt of 
pap smears than 
relying on a 
patient’s self-report 
alone. 
In 84 charts of 
women with no pap 
testing, 40.5% (34) 
had no 
documentation of 







decreased odds of 












study was obtained by 
chart review of HIV + 
females receiving pap 
smears at their HIV 
providers office 
Evaluated time to 
colposcopy after 
identification of an 
abnormal pap smear 










HSIL on pap 
CD4≥500 
NP HIV provider 
performing pap vs 
gynecological 
provider. 
Only 68% (120) 
of women who 
had abnormal 
cervical cytology 
followed up by 12 
months. 
Identification of 
barriers and follow 
up colposcopy are 
important and 
should continue to 
be studied. HIV + 
females are at an 
increased risk of 
invasive cervical 
cancer.  
Delays in follow-up 




HIV + females are 
less likely to have 
regression of 
cervical dysplasia. 




review of perinatally 
infected girls, ages 13 
or over, enrolled in 
Protocol 219 C, who 
were sexually active 
and underwent 




This study found 
that of the 174 
girls known to be 
sexually active, 
only 101 had 
underwent pap 
testing. Of the 101 
cases reviewed, 
30 had abnormal 
cytology at 
baseline and only 












This study found 






cytology on their 
initial pap smear.  
The 
recommendation is 





the first year of 
onset of sexual 
activity or age 21 











excision or both. 
Bynum et al. 
(2016) 
Questionnaire based 
study of HIV positive 
females, 18 years or 
older, receiving care at 
an AIDS service 
organization located in 
the South East United 
States. 
Used descriptive 

















not have a 
personal health 
care provider 




were (a) low 
access to health 





Many women noted 
that their HIV 
provider was the 
only provider that 
they received care 
from.  Due to this 
fact it should be 
priority to provide 
women’s health 
services such as 
cervical cancer 
screening within 
the HIV primary 
setting.   
 
Factors such as 
transportation and 
perceptions of 
stigma should also 
be considered when 
determining what 
services to provide 
within the HIV care 
setting.  Many 
women feel 
stigmatized when 
seeking care from 
health care 
providers who are 
not aware of their 
HIV status and feel 
uncomfortable 
disclosing.   
 





intimate and that 
can be utilized to 
provide screening 
within the HIV 
clinic setting.  




comparative study of 
pre-and post-
intervention data after 
introduction of a 
quality improvement 


















factors, and time. 
Post-intervention 
the clinic saw a 




approach should be 




disease clinic.  
The gains can be 
sustained by 
interventions that 
are sustainable and 







should be a priority 
for the HIV 
provider.  
Patient barriers 
such as lack of 
education on the 
importance of 
screening for 
cervical cancer as 




























were infected with 
high-risk strains 
of HPV. 




were infected with 
high-risk strains 
of HPV. 





were infected with 
high-risk strains 
of HPV. 
This study looked 
at the number of 
women who had 
normal cervical 
cytology were co-
infected with high 
risk strains of 
human papilloma-
virus (HPV).  HPV 
co-infection 
contributes to the 
largest percentage 
of cervical cancers.  
Due to this fact, 
HPV co-testing 
should be provided 








of HIV positive 
females who had 
minimally abnormal 
cervical cytology, who 
also received 
recommended follow 
up colposcopy within 
a 6-month time. The 
phenomenon of 
interest was the 
number of women 
who had CIN2+ 
confirmed with 
histology results after 
having cervical 
cytology of ASC-US 




females have an 










655 HIV positive 
women received a 
pap during the 
study period. 
 
146 (22%) had 
ASC-US/LSIL on 
index pap. 
This study analyzed 
the difference in 
HIV positive 









It is not known if 
the higher 
incidence of high-
grade dysplasia in 
HIV positive 
women was due to 
increased 
progression from a 














were found to have 
a statistically 
significant increase 




adjusted OR 2.17, 
95%CI (1.33-3.62). 
 
Due to this 
difference it is of 
great importance 
















Systematic review  
 
Incidence: 
Included 15 cohort 
studies with 
observational data 




Included 11 cohort 
studies with data from 






that cause cancer 







HPV infection.  
Women with HIV 
have an incidence 
rate of cervical 
abnormality three-
fold their negative 
HIV-positive 
females have a 
higher incidence of 
cervical cancer and 
cervical dysplasia 
progresses faster in 
HIV-positive 
females than their 
non-infected 
counterparts.  
 It would be 
advantageous to 
integrate women’s 






women are twice 
as likely to have 
cervical lesions 
that progress in 
severity. The use 
of ART/HAART 










Focus groups guided 
by the Health Belief 
Model 
 
Participants were HIV 
positive females, 
receiving care at an 
HIV clinic in Houston, 






discomfort of both 
pap and follow up 
procedures, lack 
of awareness that 












increased risk for 
cervical cancer. 
Holistic approaches 
to HIV/AIDS care 
should include 






should be used and 
cervical cancer 
screening should be 
integrated into HIV 
care. 
Frazier et al. 
(2016) 
Cross-sectional 
analysis of weighted 
data retrieved from 
chart reviews of 
women who received 
care at specific sites. 
 
Logistic regression to 
compute adjusted 
prevalence ratios and 
95% CI 
STI and cervical 
cancer screening 
are suboptimal in 
HIV + women.  
Factors that affect 
screening rates 
were age ≥50, not 
sexually active, no 
OBGYN provider, 
low income, 
depression, and no 
STI testing. 
Even in women 
receiving 
appropriate HIV 
care cervical cancer 
screening was 
found to be 
suboptimal.  









testing for sexually 
transmitted 
infections with HIV 





engagement of HIV 
positive women to 
receive cervical 
cancer screening 




be deployed and 
are an important 
aspect of providing 








used to compare 
accuracy of self-report 
preventative cancer 















cervical and breast 
cancer should be 
confirmed by 







study that reviewed 
health record of HIV 
positive females 
receiving care at a 
clinic in New Haven, 















Women with HIV 
are found to more 
economically 
disadvantaged 
compared to HIV 
positive men and 
report greater 
obstacles to 




rates of cervical 
cancer screening 
are lowest among 
infectious disease 
specialists (47% 
vs 55% for 
generalist). 
Issuing referrals for 
outside providers 
for cervical cancer 
screening may 
decrease the 
number of females 





the HIV positive 




resources should be 
considered in the 
primary HIV care 
setting.  
 
There is potential 
improvement to 
integrate women’s 
health into HIV 
primary care and 
provide a source 
for in-house 
screening. 
Leece et al. 
(2010) 
Retrospective cohort 
study of HIV positive 
females engaged in 
care at a tertiary care 
HIV clinic located in 
Ottawa, Ontario 
between July 1, 2002 
and June 30, 2005 
 
N=218 
Only 58% of 
participants had at 
least one pap 
smear during a 3-
year period of 
care. 
33% of the 
females who did 
undergo cervical 
cancer screening 
had an abnormal 
result 
HIV positive 
women without a 
primary care 
provider are less 





definition of a 
primary care 
provider, for HIV 











patients deserve the 
same type of 

















chart review of 200 
women receiving HIV 
care at a Florida 
Health Department 
between January 2000 
and May 2006 
N= 200 
83 % of HIV 
positive women 
received a pap 
smear during the 
first year after 
diagnosis.  Only 
24.5% received a 
second pap smear 






related to receipt 
of cervical cancer 
screening as 
64.7% of women 
who had not 
received a pap 




Integration of HIV 
primary care and 
gynecological care 













which often by 
definition is the 
HIV care provider. 
 
There should be a 
mechanism in place 
to ensure proper 






and follow up.  

















states have been 
noted to decrease 
clearance of HR 
HPV infections in 
HIV positive 
women, this study 
did not find a 
correlation 
between HPV 
presence and CD4 
or viral load. 
Presence of high-
risk strains of HPV 
should be evaluated 
in HIV positive 





for further research 
to determine if the 
presence of HR 
HPV in the 
presence of normal 
cervical cytology is 
a predictor of 
cervical dysplasia 
or cancer over time. 









care for breast or 
cervical cancer 
diagnosis at federally 







were (a) lack of 
knowledge of 
resources, (b) 
denial or fear, (c) 
competing 
obligation and (d) 
embarrassment.  







and (d) motivation 




interventions are an 
important aspect of 
compliance to 
follow up in 




address barriers to 
health care for 
vulnerable 
populations is 











qualitative data review 
 
Data was reviewed of 
HIV positive females 
interviewed in sites 
located in 18 states. 
 Reasons for not 
getting annual pap 
smears was reviewed 
and logistic regression 




23% of women 
reported not 
receiving pap 
smears.  Chance 




age, lower CD4 
counts, and not 
receiving pap 











should be discussed 
with patients. 
Integration of HIV 
and gynecological 
care should be 
implemented if 











HPV 16 alone 
accounts for 50% 
of cervical 
cancers within the 
general 
population.  HPV 
18 accounts for 
10-15% and all 
other high-risk 
strains of HPV 
account for less 
than 5% each.  
HPV has an 
increased 
prevalence in 
women prior to 
age 30, therefore 
routine HPV co-
testing should not 
be performed in 
this age group.  
HIV positive 
women who are 
sexually active 
and ages 21 and 
younger may have 
a higher rate of 
progression of 
Cervical cancer 
screening should be 
started within one 
year of sexual 
activity, regardless 
of mode of 
transmission and 
continue through-
out the patient’s 
lifetime.  HPV co-




three years if both 
cervical cytology 
and HPV are 
negative for women 
age 30 or older. If 
HPV co-testing is 
not performed then 
a cervical cytology 
should be 
performed every 
year until the 
patient has three 
consecutive results 





women in older 
age groups as well 
as HIV negative 
females. 
then every three 
years is adequate. 
For women, less 
than 30 years of 
age cervical 
cytology should be 
performed 
annually, and HPV 
testing should only 
be ordered as a 
reflex for abnormal 
results. Follow up 
for ASC-US with 
positive HPV and 





up. Normal cervical 
cytology with HPV 
16 or 18 detected 
also require referral 






study of medical 
records of HIV 
positive women 
receiving care at a 
county-based HIV 
clinic in San Mateo, 





Out of the women 
who met inclusion 
criteria (receiving 
care for a 
continuous period 
of 12 months) 
77.9% (53) 
received at least 
one cervical 
cancer screening 
during the study 
period.  59.5% 
(47) who had 
normal cervical 
cytology had a 
subsequent 
screening within 
18 months of the 
first.  33.3% (23) 
women had one or 
Due to increased 
incidence of 
cervical dysplasia 
and cervical cancer 
in HIV positive 
women, education 
and promotion of 
cervical cancer 
screening should be 
vigorously 
provided to women 
seeking care within 










pap smears. Only 
62% of women 
who had abnormal 
cervical cytology 
had follow up 
within one year. 




Simonsen et al.  
(2014) 
Retrospective cohort 
study of HIV positive 
women receiving care 
at the University of 
Utah’s Infectious 
















One-third of the 
HIV positive 





are less likely to 
receive a pap 
smear (p=0.025). 
 
This correlation  
could be due to 









receive care at 
Ryan White 
Funded clinics 
often do not have 
access to care 
outside of the 
clinic. Therefore, 
efforts should be 
made to provide 
preventative health 
care, such as 
cervical cancer 
screening within 
the clinic setting. 
 














Efforts should be 
made to incorporate 
cancer screenings, 
STI testing, and 
safe-sex counseling 
from both a 













interviews based on 
the health belief model 
and the PEN-3 to 
ascertain why women 
do or not undergo 






did not undergo 
cervical cancer 
screening such as 
(a) lack of 
knowledge of risk, 
(b) fear of 
negative 








It was noted that 
lack of education 
was a significant 
theme noted in both 
women who had 
paps and those who 
had not.  This fact 
makes it possible 
that provider-
initiated referrals 
and suggestions for 
cervical cancer 





and evaluation of 
health education 
interventions 
















APPENDIX D – Self-Certification Form for Determining Whether a Proposed Activity is 
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